LKFT · Lakefront Biotherapeutics NV · Documents

$32.28 -0.05 (-0.15%) At close · Oct 30 Q1 2026 earnings call transcript

Market Cap

$2.13B

65.90M

Volume · Oct 30 164.06K Avg daily vol (3M) 283.93K

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2024-03-29	—
20-F	—	2024-03-28	2023-12-31
6-K	—	2024-02-23	2024-02-22
6-K	—	2024-02-16	2024-02-15
6-K	—	2024-02-06	2024-01-31
6-K	—	2024-01-05	2024-01-04
6-K	—	2024-01-04	2024-01-03
6-K	—	2024-01-04	2024-01-02
6-K	—	2023-12-21	2023-12-19
6-K	—	2023-12-12	2023-12-07
6-K	—	2023-12-12	2023-12-09
6-K	—	2023-11-03	2023-11-02
6-K	—	2023-11-02	2023-10-30
6-K	—	2023-09-20	2023-09-19
6-K	—	2023-08-30	2023-08-28
6-K	—	2023-08-04	—
6-K	—	2023-06-15	—
6-K	—	2023-06-13	—
6-K	—	2023-06-12	—
6-K	—	2023-05-26	2023-05-23
6-K	—	2023-05-23	2023-05-22
6-K	—	2023-05-09	2023-05-05
6-K	—	2023-05-05	2023-05-04
6-K	—	2023-05-02	2023-04-26
6-K	—	2023-05-02	—
6-K	—	2023-04-26	2023-04-25
6-K	—	2023-04-25	—
6-K	—	2023-03-31	2023-03-30
6-K	—	2023-03-27	—
20-F	—	2023-03-23	2022-12-31
6-K	—	2023-03-23	2023-03-20
6-K	—	2023-02-28	2023-02-27
6-K	—	2023-02-24	2023-02-23
6-K	—	2023-02-10	2023-02-09
6-K	—	2023-02-08	—
6-K	—	2023-01-19	—
6-K	—	2023-01-10	—
6-K	—	2023-01-05	2022-12-23
6-K	—	2023-01-05	2023-01-03
6-K	—	2022-12-23	2022-12-22
6-K	—	2022-12-13	—
6-K	—	2022-11-14	2022-11-11
6-K	—	2022-11-09	2022-11-08
6-K	—	2022-11-07	—
6-K	—	2022-11-04	—
6-K	—	2022-10-17	—
6-K	—	2022-10-06	—
6-K	—	2022-10-04	2022-10-03
6-K	—	2022-09-27	—
6-K	—	2022-08-30	—

Showing 101–150 of 254 filings

Key facts CIK 1421876 CUSIP 36315X101 13F (30d) 14 filings 14 filers Visit website Investor relations